PEP: latest news

PEP resources

  • Sex

    Having HIV can affect people’s feelings about sex in many different ways. Some people become anxious about passing HIV on, or feel less desirable. While some people go...

    From: Booklets

    Information level Level 2
  • Dealing with sexual health problems

    Loss of sexual drive or desire (libido) can have a significant impact on quality of life and feelings of self-worth, and may contribute to emotional problems such...

    From: Living with HIV

    Information level Level 2
  • Sex

    All too often, relationships between people of different HIV status are thought of only in terms of sex and the risk of HIV transmission. Yes, sex is important to...

    From: Living with HIV

    Information level Level 2
  • Post-exposure prophylaxis (PEP)

    If you have had unprotected sex (including if a condom broke or came off during sex) or shared drug injecting equipment with somebody you know...

    From: Factsheets

    Information level Level 2
  • Post-exposure prophylaxis

    Post-exposure prophylaxis (PEP) has been in use, in healthcare settings, since 1988. Providing PEP after sexual exposure is more controversial....

    From: Preventing HIV

    Information level Level 4
  • Post-exposure prophylaxis

    Post-exposure prophylaxis (PEP) is a course of HIV medication that may block HIV infection. Although no antiretroviral has been licensed for use as prophylaxis against...

    From: HIV transmission & testing

    Information level Level 4

PEP in your own words

  • Needlestick injury

    I am an HIV-positive doctor. I was infected courtesy of a lapse in concentration and a needlestick injury at work. The prescribed dual post-exposure prophylaxis (PEP) was taken for one...

    From: In your own words

PEP news from aidsmap

More news

PEP news selected from other sources

  • Who’s been using PEP—and would they benefit from PrEP?

    With 50,000 new HIV infections occurring in the U.S. every year, it’s clear that PEP isn’t being used as often as it could be. Using data collected at a large community health center over the past 15 years, two recent studies evaluated who has been accessing and using PEP—and provide insight into how researchers and practitioners can more effectively deploy biomedical prevention strategies moving forward.

    11 June 2015 | Betablog
  • US: Only 1 Confirmed Case of Occupational HIV Acquisition Since 1999

    Only a single health care worker was confirmed to have acquired HIV on the job between 2000 and 2013, according to the CDC.

    14 January 2015 | AIDSMeds
  • NYC Health Dept. Launches PrEP, PEP Outreach Campaign

    To boost awareness of pre- and post-exposure prophylaxis (PrEP and PEP) to prevent HIV infection, the NYC Department of Health has launched an outreach program targeted to 600 doctors.

    14 January 2015 | Poz magazine news
  • Who’s to blame for misuse of HIV drugs in Kenya?

    Reports of sex workers misusing HIV drugs have left activists wondering if the government invested enough in HIV education before purchasing medicine, worth 4 billion Kenyan shilling. Many sex workers say clients prefer to have unprotected sex and will pay more money for it. This being a business, the women often choose to have unprotected sex, then rush to a public hospital for post-exposure prophylaxis medication, claiming they have been raped or had a burst condom. Some sex workers have also expressed uncertainties about the sustainability of the project, so they go to different hospitals and stockpile the medication, just in case it is no longer available in public hospitals.

    07 January 2015 | Key Correspondents
  • WHO: Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents and children

    Recommendations for a public health approach - December 2014 supplement to the 2013 consolidated ARV guidelines.

    02 December 2014 | World Health Organization
  • What to Do When a Patient Admits an H.I.V. Phobia

    She had been volunteering at a drop-in center for the homeless, helping to prepare dinner, when she felt a sting in the tip of the finger and looked down to see a red mark and a dot of blood. She could not find the object that had poked her, but she knew immediately what might have happened: She had seen a few used syringes lying around the place, and perhaps one had somehow gotten into the sink and perhaps she had stuck her finger with it, and perhaps it had just been used by an H.I.V.-infected addict, and perhaps right that minute, the virus was coursing through her own veins. So of course she went to the nearest emergency room. She knew that medication taken promptly could prevent H.I.V., and she wasn’t taking any chances.

    16 September 2014 | New York Times
  • Change to recommended regimen for post-exposure prophylaxis (PEP)

    The Expert Advisory Group on AIDS (EAGA) has recommended a change in the recommended regimen for post-exposure prophylaxis from tenofovir/emtricitabine with Kaletra to tenofovir/emtricitabine with raltegravir.

    11 September 2014 | Expert Advisory Group on AIDS (EAGA)
  • HIV Prevention in Clinical Care Settings - 2014 Recommendations of the International Antiviral Society–USA Panel

    In an innovative approach to HIV prevention, an interdisciplinary group of experts has come together for the first time to lay out a framework of best practices to optimize the role of the clinician in achieving an AIDS-free generation.

    19 July 2014 | Journal of the American Medical Association
  • The Atlanta Principles Urge CDC to Act Now on HIV Prevention

    The document urges the CDC to address TasP, PrEP and PEP.

    11 June 2014 | Poz magazine news
  • 30 years on and still more to do to educate gay men about HIV prevention

    Thirty years after the discovery of virus, new research from NAT (National AIDS Trust) reveals that gay men are in the dark about new HIV prevention tools, with knowledge among 16-24 year olds particularly low.

    23 April 2014 | NAT press release
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.